-
Something wrong with this record ?
Cellular transformation promotes the incorporation of docosahexaenoic acid into the endolysosome-specific lipid bis(monoacylglycerol)phosphate in breast cancer
AL. Berg, MR. Showalter, N. Kosaisawe, M. Hu, NC. Stephens, M. Sa, H. Heil, N. Castro, JJ. Chen, K. VanderVorst, MR. Wheeler, Z. Rabow, T. Cajka, J. Albeck, O. Fiehn, KL. Carraway
Language English Country Ireland
Document type Journal Article, Research Support, N.I.H., Extramural
- MeSH
- Phosphates metabolism MeSH
- Docosahexaenoic Acids * MeSH
- Humans MeSH
- Lysophospholipids metabolism MeSH
- Lysosomes metabolism MeSH
- Mice MeSH
- Breast Neoplasms * pathology MeSH
- Reactive Oxygen Species metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, N.I.H., Extramural MeSH
Bis(monoacylglycero)phosphates (BMPs), a class of lipids highly enriched within endolysosomal organelles, are key components of the lysosomal intraluminal vesicles responsible for activating sphingolipid catabolic enzymes. While BMPs are understudied relative to other phospholipids, recent reports associate BMP dysregulation with a variety of pathological states including neurodegenerative diseases and lysosomal storage disorders. Since the dramatic lysosomal remodeling characteristic of cellular transformation could impact BMP abundance and function, we employed untargeted lipidomics approaches to identify and quantify BMP species in several in vitro and in vivo models of breast cancer and comparative non-transformed cells and tissues. We observed lower BMP levels within transformed cells relative to normal cells, and consistent enrichment of docosahexaenoic acid (22:6) fatty acyl chain-containing BMP species in both human- and mouse-derived mammary tumorigenesis models. Our functional analysis points to a working model whereby 22:6 BMPs serve as reactive oxygen species scavengers in tumor cells, protecting lysosomes from oxidant-induced lysosomal membrane permeabilization. Our findings suggest that breast tumor cells might divert polyunsaturated fatty acids into BMP lipids as part of an adaptive response to protect their lysosomes from elevated reactive oxygen species levels, and raise the possibility that BMP-mediated lysosomal protection is a tumor-specific vulnerability that may be exploited therapeutically.
Department of Molecular and Cellular Biology University of California Davis Davis CA USA
Institute of Physiology of the Czech Academy of Sciences Prague 14200 Czech Republic
West Coast Metabolomics Center UC Davis Genome Center University of California Davis Davis CA USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003736
- 003
- CZ-PrNML
- 005
- 20230425140842.0
- 007
- ta
- 008
- 230418s2023 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.canlet.2023.216090 $2 doi
- 035 __
- $a (PubMed)36773796
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Berg, Anastasia L $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
- 245 10
- $a Cellular transformation promotes the incorporation of docosahexaenoic acid into the endolysosome-specific lipid bis(monoacylglycerol)phosphate in breast cancer / $c AL. Berg, MR. Showalter, N. Kosaisawe, M. Hu, NC. Stephens, M. Sa, H. Heil, N. Castro, JJ. Chen, K. VanderVorst, MR. Wheeler, Z. Rabow, T. Cajka, J. Albeck, O. Fiehn, KL. Carraway
- 520 9_
- $a Bis(monoacylglycero)phosphates (BMPs), a class of lipids highly enriched within endolysosomal organelles, are key components of the lysosomal intraluminal vesicles responsible for activating sphingolipid catabolic enzymes. While BMPs are understudied relative to other phospholipids, recent reports associate BMP dysregulation with a variety of pathological states including neurodegenerative diseases and lysosomal storage disorders. Since the dramatic lysosomal remodeling characteristic of cellular transformation could impact BMP abundance and function, we employed untargeted lipidomics approaches to identify and quantify BMP species in several in vitro and in vivo models of breast cancer and comparative non-transformed cells and tissues. We observed lower BMP levels within transformed cells relative to normal cells, and consistent enrichment of docosahexaenoic acid (22:6) fatty acyl chain-containing BMP species in both human- and mouse-derived mammary tumorigenesis models. Our functional analysis points to a working model whereby 22:6 BMPs serve as reactive oxygen species scavengers in tumor cells, protecting lysosomes from oxidant-induced lysosomal membrane permeabilization. Our findings suggest that breast tumor cells might divert polyunsaturated fatty acids into BMP lipids as part of an adaptive response to protect their lysosomes from elevated reactive oxygen species levels, and raise the possibility that BMP-mediated lysosomal protection is a tumor-specific vulnerability that may be exploited therapeutically.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a kyseliny dokosahexaenové $7 D004281
- 650 12
- $a nádory prsu $x patologie $7 D001943
- 650 _2
- $a fosfáty $x metabolismus $7 D010710
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a lysofosfolipidy $x metabolismus $7 D008246
- 650 _2
- $a lyzozomy $x metabolismus $7 D008247
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Showalter, Megan R $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
- 700 1_
- $a Kosaisawe, Nont $u Department of Molecular and Cellular Biology, University of California Davis, Davis, CA, USA
- 700 1_
- $a Hu, Michelle $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
- 700 1_
- $a Stephens, Nathanial C $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
- 700 1_
- $a Sa, Michael $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
- 700 1_
- $a Heil, Hailey $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
- 700 1_
- $a Castro, Noemi $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
- 700 1_
- $a Chen, Jenny J $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
- 700 1_
- $a VanderVorst, Kacey $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
- 700 1_
- $a Wheeler, Madelyn R $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
- 700 1_
- $a Rabow, Zachary $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
- 700 1_
- $a Cajka, Tomas $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA; Institute of Physiology of the Czech Academy of Sciences, Prague, 14200, Czech Republic
- 700 1_
- $a Albeck, John $u Department of Molecular and Cellular Biology, University of California Davis, Davis, CA, USA
- 700 1_
- $a Fiehn, Oliver $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
- 700 1_
- $a Carraway, Kermit L $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA. Electronic address: klcarraway@ucdavis.edu
- 773 0_
- $w MED00001044 $t Cancer letters $x 1872-7980 $g Roč. 557, č. - (2023), s. 216090
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36773796 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140838 $b ABA008
- 999 __
- $a ok $b bmc $g 1924424 $s 1189945
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 557 $c - $d 216090 $e 20230210 $i 1872-7980 $m Cancer letters $n Cancer Lett $x MED00001044
- LZP __
- $a Pubmed-20230418